Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 14, 2026
Why Is International Business Machines (IBM) Stock Down -25.21% Today?

Why Is International Business Machines (IBM) Stock Down -25.21% Today?

Key Takeaways

  • IBM shares plummeted 25.21% on Tuesday, closing at $217.05 versus a prior close of $290.23, marking the worst single-day decline in the company's modern trading history.
  • The primary catalyst was a surprise preliminary second-quarter earnings release that revealed both revenue and profit fell well short of Wall Street expectations.
  • CEO Arvind Krishna attributed the shortfall to an unprecedented shift in enterprise client spending toward AI-related hardware—servers, storage, and memory chips—at the expense of IBM's core software and mainframe businesses.
  • The selloff sent shockwaves through the broader technology sector, dragging down software peers such as MSFT, CRM, and NOW, while memory chip makers like MU rallied.
  • HSBC downgraded the stock from Hold to Reduce, slashing its price target, while traders now turn their attention to the official earnings release scheduled for July 22.

Opening Summary

International Business Machines (IBM), the 115-year-old technology giant known for its enterprise hardware, software, and consulting services, suffered a historic rout on Tuesday. Shares of IBM closed at $217.05, down 25.21% from the previous session's close of $290.23. The collapse was triggered by the company's unexpected early release of preliminary second-quarter results, which showed adjusted earnings of $2.93 per share on revenue of $17.2 billion—both missing consensus analyst estimates of $3.01 per share and $17.86 billion, respectively. CEO Arvind Krishna candidly told investors that the company "faltered" in adapting to a rapid reprioritization of client spending toward AI infrastructure.

Preliminary Earnings Miss Catches Wall Street Off Guard

In a highly unusual move, IBM released preliminary second-quarter figures a full week ahead of its scheduled July 22 earnings report. The numbers painted a sobering picture. Software revenue grew just 5%, roughly half the 10% growth analysts had projected. Infrastructure revenue declined 7%, worse than the expected 3% drop. Consulting revenue was flat. Krishna's letter to shareholders acknowledged that the company had anticipated some supply-chain headwinds but "did not anticipate the magnitude of the capex reprioritization" that unfolded in the final weeks of June.

AI Infrastructure Spending Crowds Out IBM's Core Business

The central theme of Tuesday's selloff was a structural shift in enterprise technology budgets. As corporations race to build out artificial intelligence capabilities, they are funneling capital toward servers, storage, and high-bandwidth memory chips—components essential for training and running AI models. Krishna noted that clients scrambled to secure supply-constrained infrastructure ahead of expected price increases, leaving less budget for the mainframe systems and associated software that form the backbone of IBM's traditional business. The company's flagship z17 mainframe, which had its strongest launch in company history, saw a "shortfall" in sales as large deals failed to close on expected timelines.

Execution Failures and Cybersecurity Distractions

Beyond the macro spending shift, Krishna admitted to internal missteps. "These conditions require our teams to execute perfectly, and this quarter we faltered," he wrote. "We did not adapt and move quickly enough, and numerous large deals failed to close on the timelines we expected, driving the majority of our shortfall." He also cited rapidly evolving cybersecurity concerns—including the emergence of advanced AI models capable of uncovering system vulnerabilities—as a factor that distracted enterprise clients and delayed purchasing decisions during the quarter.

Market Context and Trading Activity

Trading volume in IBM surged to more than 67 million shares, dwarfing the stock's average daily volume and reflecting the intensity of the selloff. The decline was the worst single-day performance for IBM since at least 1968, surpassing even the 23.7% drop recorded on Black Monday in October 1987. The rout rippled across the technology landscape: software names like NOW, CRM, and WDAY fell sharply in sympathy, while memory chip manufacturers MU and SNDK rallied as investors bet on the same hardware spending wave that punished IBM. The Dow Jones Industrial Average, of which IBM is a component, was weighed down by the stock's decline.

Trending AI Robots

In volatile market environments like today's, traders increasingly turn to automated strategies to navigate sharp price swings. Tickeron's Trending AI Robots page features a curated selection of AI-powered trading bots that have demonstrated strong performance under current market conditions. With hundreds of bots covering thousands of tickers, the platform highlights only those strategies that are currently excelling—whether through momentum trading, swing trading, or mean-reversion approaches. Each bot varies by strategy, timeframe, and performance metrics, allowing users to identify tools aligned with their trading style. Explore the Trending AI Robots page to see which automated strategies are adapting best to today's market dynamics.

What Comes Next for IBM

Investors now await IBM's official second-quarter earnings release on July 22, when management is expected to provide a more detailed breakdown of segment performance and forward guidance. Krishna indicated the company is "undertaking new initiatives and accelerating others" to improve results, but the path forward remains uncertain. Analysts at HSBC have already downgraded the stock to Reduce with a lowered price target of $191. Key areas of focus will include whether Red Hat revenue growth—which accelerated to 11% in the quarter—can offset mainframe weakness, and whether the company's ambitious quantum computing roadmap, including a planned fault-tolerant quantum computer by 2029, can restore investor confidence. Broader risks include the ongoing reprioritization of enterprise IT budgets toward AI hardware and the potential for further software-sector disruption.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IBM

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


IBM in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 14, 2026

IBM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where IBM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IBM's RSI Oscillator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 28, 2026. You may want to consider a long position or call options on IBM as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IBM just turned positive on July 31, 2026. Looking at past instances where IBM's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in of 374 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

IBM moved below its 50-day moving average on July 14, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IBM crossed bearishly below the 50-day moving average on July 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.452) is normal, around the industry mean (7.293). P/E Ratio (20.957) is within average values for comparable stocks, (71.740). IBM's Projected Growth (PEG Ratio) (2.401) is slightly higher than the industry average of (1.207). Dividend Yield (0.029) settles around the average of (0.025) among similar stocks. P/S Ratio (3.250) is also within normal values, averaging (148.828).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IBM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 9.31B. The market cap for tickers in the group ranges from 0 to 222.32B. IBM holds the highest valuation in this group at 222.32B. The lowest valued company is ARSC at 0.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was 0%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 65%. CACI experienced the highest price growth at 31%, while TTEC experienced the biggest fall at -41%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was -10%. For the same stocks of the Industry, the average monthly volume growth was -9% and the average quarterly volume growth was -42%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 64
Price Growth Rating: 57
SMR Rating: 72
Profit Risk Rating: 92
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
IBM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of various computer products through the use of advanced information technology

Industry InformationTechnologyServices

Profile
Details
Industry
Information Technology Services
Address
One New Orchard Road
Phone
+1 914 499-1900
Employees
305300
Web
http://www.ibm.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.